Four areas
shaping the new frontier.
The 2027 program is structured around four areas where space and life sciences converge. The full agenda — sessions, speakers and side-events — will be revealed progressively through 2026.
Below are the topics already confirmed for plenary, working-group and roundtable formats.
Medical Advances from Space
Disease modelling and therapeutics: oncology, rare diseases, neurodegenerative diseases, regenerative medicine, gene and cell therapies, new generation of antibiotics, cardiology, ophthalmology and more — for breakthroughs in human health.
Innovation in Pharmaceuticals & Cosmetics
Active pharmaceutical ingredients, anti-aging and longevity, cosmetics, regulatory frameworks (GLP/GMP), space and AI, deep-tech for pharmaceuticals, patent cliffs and IP issues.
Space Infrastructure & In-Space Manufacturing
Access and return from space, space platforms, advanced autonomous laboratories, robotics, advanced production techniques, space as a new industrial zone for health — biomaterials and biotherapies.
Market & Economics
Market trends, business models, socio-economic benefits, key performance indicators, institutional and private investment strategies, show-stoppers and accelerators, success stories and challenges.
Request the full program as soon as it's available.
We'll send you the agenda, speaker line-up and side-event schedule the moment they're published.